BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu X, Davis CM, Alkayed NJ. P450 Eicosanoids and Reactive Oxygen Species Interplay in Brain Injury and Neuroprotection. Antioxid Redox Signal 2018;28:987-1007. [PMID: 28298143 DOI: 10.1089/ars.2017.7056] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Bah TM, Allen EM, Garcia-Jaramillo M, Perez R, Zarnegarnia Y, Davis CM, Bloom MB, Magana AA, Choi J, Bobe G, Pike MM, Raber J, Maier CS, Alkayed NJ. GPR39 Deficiency Impairs Memory and Alters Oxylipins and Inflammatory Cytokines Without Affecting Cerebral Blood Flow in a High-Fat Diet Mouse Model of Cognitive Impairment. Front Cell Neurosci 2022;16:893030. [PMID: 35875352 DOI: 10.3389/fncel.2022.893030] [Reference Citation Analysis]
2 Lansdell TA, Chambers LC, Dorrance AM. Endothelial Cells and the Cerebral Circulation. Compr Physiol 2022;12:3449-508. [PMID: 35766836 DOI: 10.1002/cphy.c210015] [Reference Citation Analysis]
3 Kumar N, Kumar V, Anand P, Kumar V, Ranjan Dwivedi A, Kumar V. Advancements in the development of multi-target directed ligands for the treatment of Alzheimer's disease. Bioorg Med Chem 2022;61:116742. [PMID: 35398739 DOI: 10.1016/j.bmc.2022.116742] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
4 Siler DA, Semonche AM, Samatham R, Liu JJ, Martini RP, Alkayed NJ, Hinson HE, Cetas JS. Eicosanoid Ratios are Associated with Hemorrhage Severity and Predict Development of Delayed Cerebral Ischemia Following Subarachnoid Hemorrhage. Brain Hemorrhages 2022. [DOI: 10.1016/j.hest.2022.05.004] [Reference Citation Analysis]
5 Kuo YM, Lee YH. Epoxyeicosatrienoic acids and soluble epoxide hydrolase in physiology and diseases of the central nervous system. Chin J Physiol 2022;65:1-11. [PMID: 35229747 DOI: 10.4103/cjp.cjp_80_21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gonzalez-Fernandez E, Liu Y, Auchus AP, Fan F, Roman RJ. Vascular contributions to cognitive impairment and dementia: the emerging role of 20-HETE. Clin Sci (Lond) 2021;135:1929-44. [PMID: 34374423 DOI: 10.1042/CS20201033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Griñán-Ferré C, Codony S, Pujol E, Yang J, Leiva R, Escolano C, Puigoriol-Illamola D, Companys-Alemany J, Corpas R, Sanfeliu C, Pérez B, Loza MI, Brea J, Morisseau C, Hammock BD, Vázquez S, Pallàs M, Galdeano C. Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease. Neurotherapeutics 2020;17:1825-35. [PMID: 32488482 DOI: 10.1007/s13311-020-00854-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 13.5] [Reference Citation Analysis]
8 Chabowski DS, Cohen KE, Abu-Hatoum O, Gutterman DD, Freed JK. Crossing signals: bioactive lipids in the microvasculature. Am J Physiol Heart Circ Physiol 2020;318:H1185-97. [PMID: 32243770 DOI: 10.1152/ajpheart.00706.2019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
9 Griñán-ferré C, Codony S, Pujol E, Yang J, Leiva R, Escolano C, Puigoriol-illamola D, Companys-alemany J, Corpas R, Sanfeliu C, Loza MI, Brea J, Morisseau C, Hammock BD, Vázquez S, Pallàs M, Galdeano C. Pharmacological inhibition of soluble epoxide hydrolase as a new therapy for Alzheimer’s Disease.. [DOI: 10.1101/605055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Lendor S, Hassani S, Boyaci E, Singh V, Womelsdorf T, Pawliszyn J. Solid Phase Microextraction-Based Miniaturized Probe and Protocol for Extraction of Neurotransmitters from Brains in Vivo. Anal Chem 2019;91:4896-905. [DOI: 10.1021/acs.analchem.9b00995] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 16.7] [Reference Citation Analysis]
11 Antcliffe DB, Wolfer AM, O'Dea KP, Takata M, Holmes E, Gordon AC. Profiling inflammatory markers in patients with pneumonia on intensive care. Sci Rep 2018;8:14736. [PMID: 30283005 DOI: 10.1038/s41598-018-32938-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
12 Araújo AC, Wheelock CE, Haeggström JZ. The Eicosanoids, Redox-Regulated Lipid Mediators in Immunometabolic Disorders. Antioxid Redox Signal 2018;29:275-96. [PMID: 28978222 DOI: 10.1089/ars.2017.7332] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]